P14.79 Randomized phase II trial of Tumor Treating Fields plus radiation therapy plus temozolomide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma

BACKGROUND: In last decade, there were numerous attempts to improve the outcome of patients with glioblastoma (GBM), but even after maximal surgical resection, radiation therapy (RT) and temozolomide (TMZ), followed by maintenance TMZ for 6 months the median OS is 14.6 months. In the EF-14 Phase III...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Limon, D, Bokstein, F, Blumenthal, D, Ben Harush, C, Ram, Z, Grossman, R
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Poster Presentations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795840/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.314
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker